Ziyad Al-Aly, MD, and Simon Haroutonian, PhD, discuss their findings that suggest COVID-19 infection raises the risk for kidney problems, heart issues, diabetes, peripheral neuropathy and psychiatric disorders, such as depression and anxiety.
Podcast: Vaccines and COVID-19 infection generate protective antibodies, even against delta (Links to an external site)
This episode focuses on the work of scientist Ali Ellebedy, PhD, who has published several papers about the immune response to vaccines and COVID-19 infection.
Grant: School-based COVID-19 testing initiative focuses on vulnerable populations (Links to an external site)
(July 15, 2021) WashU Med researchers have received $8 million from the NIH for projects studying whether frequent COVID-19 testing can reduce the spread of the virus.
Study: COVID-19 vaccines likely induce strong, persistent immunity (Links to an external site)
(July 15, 2021) A WashU Med study finds that the immune response to the first two COVID-19 vaccines approved for emergency use is both strong and potentially long-lasting.
Study shows how COVID-19 increases risk of pregnancy complications
The study helps explain why coronavirus infection has been linked to serious pregnancy complications, such as preeclampsia, that threaten the health of both mother and fetus.
Podcast: A year later, scientists recall efforts to jump-start COVID-19 research (Links to an external site)
Sean Whelan and Michael Diamond teamed up early in the pandamic to ramp up COVID-19 research while the rest of the world was shutting down.
COVID-19 survivors have increased risk of death, illness six months out (Links to an external site)
A WashU Med study shows that even mild cases of COVID-19 increase the risk of death in the six months following diagnosis. Risk increases with disease severity.
WashU Med study to evaluate breakthrough cases
The study aims to determine who is more likely to develop a breakthrough case.
For breastfeeding moms, COVID-19 vaccinations may also protect babies (Links to an external site)
Vaccinated, nursing moms may pass protective antibodies to their babies for at least 80 days , suggests new research from WashU Med.
Study: Vaccine effectiveness in people taking immunosuppressants
Alfred Kim has initiated a clinical trial to evaluate the antibody response in patients taking immunosuppressant drugs. He is recruiting WashU Med health-care workers and patients.